Gerald Shepps, MD
Glaucoma Specialist · New York, NYNPI 1538277603
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,975 of the $2,507 with a category attached, or 78.8%. 13 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 40.9% of the total. That places this record below the midpoint for glaucoma specialist clinicians in NY, where the typical reported total is $2,507.
Across 85 payments — averaging $29.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$684
- AbbVie$225
- Tarsus Pharmaceuticals, Inc.$205
- Bausch & Lomb Americas Inc.$71
- Harrow Eye, LLC$70
- plus $226 from 7 others
What the payments were for
- Consulting fees$53221%
- Food & beverage$1,97579%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 10 | $1,026 |
| Alcon | 37 | $684 |
| AbbVie(2 entities) | 12 | $225 |
| Tarsus Pharmaceuticals, Inc. | 8 | $205 |
| Bausch & Lomb Americas Inc. | 4 | $71 |
| Harrow Eye, LLC | 2 | $70 |
| Sun Pharmaceutical Industries Inc. | 3 | $57 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $56 |
| Novartis | 2 | $35 |
| Johnson & Johnson Vision Care, Inc. | 1 | $22 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
| Carl Zeiss Meditec USA, Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,507 in reported general payments places this provider in the 50th percentile of 35 glaucoma specialist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 76 | $46,499 |
| CombiganBrimonidine Tartrate/Timolol | 85 | $39,999 |
| RestasisCyclosporine | 29 | $27,657 |
| Timolol Maleate | 552 | $25,685 |
| Prednisolone Acetate | 382 | $21,790 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 99 | $13,434 |
| RocklatanNetarsudil Mesylat/Latanoprost | 13 | $11,795 |
| Travoprost | 61 | $11,135 |
| Alphagan PBrimonidine Tartrate | 22 | $10,001 |
| Brimonidine Tartrate | 109 | $9,919 |
| Timolol MaleateTimolol Maleate/Pf | 11 | $5,174 |
| Latanoprost | 563 | $4,644 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 22 | $4,368 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 53 | $1,988 |
| Brinzolamide | 15 | $1,951 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Restasis, Alphagan P | $225 | $124,155212 claims |
| AlconSimbrinza | $684 | $4,36822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 35 glaucoma specialist providers in New York.
Other glaucoma specialist in New York
- Janet SerleNew York$103K
- Sarah VantasselNew York$76K
- Sonya DharNew York$19K
- Yvonne OkakaNew York$5K
- Varun ReddyNew York$4K
- Eileen ChangNew York$3K
- Paul PetrakosNew York$3K
- Nehali NantiNew York$2K
- Johnny LiNew York$2K
- Louis PasqualeNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.